Physician profile
David Maine
NPI 1962568048
$24,411.88
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $74.01 · 2023: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $24K · Food and Beverage: $23.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $24,000.00 |
| Food and Beverage | $23.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $24,000.00 | 2023 | |
| Nevro Corp. | $223.76 | 2019-2020 | |
| Boston Scientific Corporation | $56.96 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Pfizer INC. | $47.41 | 2019-2020 | |
| Si-Bone, INC. | $28.73 | 2019 | |
| Stimwave Technologies Incorporated | $19.97 | 2019 | |
| Electronic Waveform Lab, INC. | $17.53 | 2019 | |
| Convatec INC. | $17.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$19,050.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Maine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.